James Richardson is a Professor of Orthopaedics at Keele University.
He received his MD from Aberdeen University and studied in several Centres across the UK before reaching Oswestry. His studies began with the biomechanics of fracture healing, but even then he studied cells in culture. His focus is now on the repair of cartilage, in particular with the use of autologous chondrocytes (cartilage cells) cultured from the patient to be treated.
At the Oswestry Robert Jones & Agnes Hunt Orthopaedic Hospital NHS Trust James Richardson is responsible for co-ordinating diagnosis, treatment and research of patients with chondral (cartilage) defects. He is the Clinical Director of Oscell, a MHRA approved cell production facility operating at the NHS Trust. As Director of the Institute of Orthopaedics he has a role in enabling courses run by the Institute and a series of books published to provide education in orthopaedics.
Different clinical trials such as ACTIVE, ASCOT and REACT are run with the intention of developing and testing cell therapies in orthopaedics. He is Principal Investigator on two MRC grants and a Co-Investigator for the Arthritis Research UK Tissue Engineering Centre grant